A molecular epidemiological investigation of Mycobacterium tuberculosis isolates collected in Shantou, China, has identified substantial drug resistance alongside specific genotypic variations across clinical strains. Analyzing 148 isolates collected during 2024, researchers observed that 31.8 percent exhibited phenotypic resistance to at least one tested therapeutic agent, while 98.6 percent harbored detectable genetic mutations across analyzed resistance-associated loci. The findings, published in BMC Microbiology, outline how distinct bacterial genotypes align with specific resistance profiles in the regional patient population.
Drug susceptibility testing was performed using Löwenstein-Jensen medium. Among the tested isolates, resistance to isoniazid proved most prevalent, detected in 20.9 percent of the samples. Streptomycin resistance followed at 10.1 percent, whereas resistance to rifampicin and ethambutol was each recorded at 6.2 percent across the cohort.
Patient treatment history emerged as a notable factor influencing the frequency of drug resistance in the evaluated cohort. Retreated cases accounted for 20.4 percent of the total sample group and demonstrated a significantly higher level of overall drug resistance compared with newly diagnosed cases (p < 0.05).
Genetic analysis of resistance-associated gene fragments was carried out by polymerase chain reaction amplification followed by mutation analysis with SnapGene software. Among the identified alterations, the katG Arg463Leu mutation was present in 66.2 percent of the evaluated strains, while the gyrA Ser95Thr variant was detected in 98.0 percent of the isolates.
Genotyping across the isolate collection was executed using IS6110 insertion elements alongside an 8-locus MIRU-VNTR platform, followed by phylogenetic tree reconstruction in MEGA11 using the Neighbor-Joining method. MIRU-VNTR analysis successfully differentiated 134 unique genotypes across the 148 isolates, establishing an overall clustering rate of 9.46 percent.
Phylogenetic and genotypic profiling further revealed that Lineage 2 strains served as the dominant circulating strains within the Shantou cohort. Within this lineage, researchers detected resistance-associated mutations restricted specifically to the inhA, rpsL, rrs, and pncA genes. The investigation utilized Fisher’s exact test and chi-squared tests to evaluate associations between specific genotype mutations and phenotypic resistance, as well as variations arising between the different genotyping systems applied.
The authors concluded that the identified resistance mutation patterns exhibit localized regional characteristics while remaining consistent with Erdman and CDC1551 standard strains.
Subject of Research: Molecular epidemiology and drug-resistance mutation profiling of Mycobacterium tuberculosis in Shantou, China
Article Title: Molecular epidemiology of drug-resistant Tuberculosis in Shantou, China: associations between drug resistance and genotypic variation
Article References: Xu, Y., Zhao, W., Gi, L., Chen, S., Chen, C., Ye, L., Fang, Z., Liu, S., Yao, X., Huang, X., Chen, Z., Lin, J., Chang, Q., & Lu, J. (2026). Molecular epidemiology of drug-resistant Tuberculosis in Shantou, China: associations between drug resistance and genotypic variation. BMC Microbiology. https://doi.org/10.1186/s12866-026-05849-0
Image Credits: AI Generated
DOI: 10.1186/s12866-026-05849-0
Keywords: Mycobacterium tuberculosis, Tuberculosis, Drug-Resistant Tuberculosis, Isoniazid, Streptomycin, Rifampicin, Ethambutol, Molecular Epidemiology, MIRU-VNTR Genotyping, IS6110, katG Mutation, gyrA Mutation, Lineage 2, Shantou, BMC Microbiology, Drug Susceptibility Testing
News Source: Drew Townsend. (November 13, 2026). Study Uncovers Drug-Resistant Tuberculosis Mutations and Lineage Patterns in Shantou. Scienmag.



